Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma
Authors
Keywords
-
Journal
PLoS One
Volume 13, Issue 10, Pages e0205864
Publisher
Public Library of Science (PLoS)
Online
2018-10-17
DOI
10.1371/journal.pone.0205864
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer
- (2018) Keita Kojima et al. PLoS One
- DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer
- (2017) Hideki Ushiku et al. Gastric Cancer
- Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease
- (2017) Kazuharu Igarashi et al. PLoS One
- Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) J. W. Valle et al. ANNALS OF ONCOLOGY
- Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study
- (2016) Jennifer A. Flemming et al. CANCER
- The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma
- (2016) K. Kojima et al. DISEASES OF THE ESOPHAGUS
- CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients
- (2016) Sebastian Meller et al. Epigenetics
- The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma
- (2016) K. Kojima et al. DISEASES OF THE ESOPHAGUS
- Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer
- (2016) Naoko Minatani et al. PLoS One
- Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome
- (2015) I. A. G. Deckers et al. CLINICAL CANCER RESEARCH
- Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
- (2015) Kim Andresen et al. HEPATOLOGY
- Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification
- (2014) Gia L. Tyson et al. DIGESTIVE DISEASES AND SCIENCES
- The novel colorectal cancer biomarkersCDO1, ZSCAN18andZNF331are frequently methylated across gastrointestinal cancers
- (2014) Hege Marie Vedeld et al. INTERNATIONAL JOURNAL OF CANCER
- Detection of Methylated CDO1 in Plasma of Colorectal Cancer; A PCR Study
- (2014) Keishi Yamashita et al. PLoS One
- Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
- (2012) Kim Andresen et al. Epigenetics
- Cysteine Dioxygenase 1 Is a Tumor Suppressor Gene Silenced by Promoter Methylation in Multiple Human Cancers
- (2012) Mariana Brait et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started